HROW insider transaction filings
HARROW, INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-17. Screen HROW transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 1 Form 4 filing. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing by 1 insider — 11,250 shares, $450,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
- Largest priced transaction: sale of 11,250 shares @ $40.00 ($450,000) by Shojaei Amir, filed 2026-08-17.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Shojaei Amir — CHIEF SCIENTIFIC OFFICER | 1 | — | 1 leg · 11,250 sh · $450,000 | 2 |
Recent Form 4 filings — HARROW, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-17 | 4 | Shojaei Amir — CHIEF SCIENTIFIC OFFICER | Option exercise (M): 11,250 @ $35.96 · Sale (S): 11,250 @ $40 · Option exercise (M): 11,250 (derivative) @ $35.96 | EDGAR |
| 2026-06-22 | 4 | Sternberg Perry J. — Director | Grant/award (A): 5,248 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Graves Adrienne L — Director | Grant/award (A): 5,248 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | SILVERNAIL LAUREN P — Director | Grant/award (A): 5,248 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Graves Adrienne L — Director | Purchase (P): 1,000 @ $31.07 | EDGAR |
| 2026-05-19 | 4 | SILVERNAIL LAUREN P — Director | Purchase (P): 1,000 @ $31 | EDGAR |
| 2026-05-18 | 4 | Shojaei Amir — CHIEF SCIENTIFIC OFFICER | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-05-15 | 4 | BOLL ANDREW R. — PRESIDENT AND CFO | Purchase (P): 3,500 @ $29.90 | EDGAR |
| 2026-05-15 | 4 | BAUM MARK L — CHIEF EXECUTIVE OFFICER, Director | Purchase (P): 10,000 @ $30.20 | EDGAR |
| 2026-03-05 | 4 | Opaleye Management Inc. — 10% owner | Sale (S): 59,000 @ $39.15 · Sale (S): 1,309 @ $39.15 · Sale (S): 134,000 @ $39.67 · Sale (S): 4,263 @ $39.67 | EDGAR |
| 2026-03-03 | 4 | Opaleye Management Inc. — 10% owner | Sale (S): 5,000 @ $54.18 | EDGAR |
| 2026-02-02 | 4 | Sullivan Patrick William — CHIEF COMMERCIAL OFFICER | Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | Opaleye Management Inc. — 10% owner | Sale (S): 20,000 @ $53.35 | EDGAR |
| 2025-12-16 | 4 | BOLL ANDREW R. — PRESIDENT AND CFO | Option exercise (M): 60,000 @ $3.95 · Tax withholding (F): 26,665 @ $47.06 · Option exercise (M): 60,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | BAUM MARK L — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 180,000 @ $3.95 · Tax withholding (F): 79,994 @ $47.06 · Option exercise (M): 180,000 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | Pollard Randall E. — CHIEF ACCOUNTING OFFICER | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-07-23 | 4 | BAUM MARK L — CHIEF EXECUTIVE OFFICER, Director, 10% owner | Option exercise (M): 600,000 @ $7.87 · Tax withholding (F): 313,338 @ $37.08 · Option exercise (M): 600,000 (derivative) @ $0 | EDGAR |
| 2025-07-01 | 4 | BOLL ANDREW R. — CHIEF FINANCIAL OFFICER | Grant/award (A): 405,750 (derivative) @ $0 | EDGAR |
| 2025-07-01 | 4 | BAUM MARK L — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 889,500 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | Sternberg Perry J. — Director | Grant/award (A): 7,339 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | Graves Adrienne L — Director | Grant/award (A): 7,339 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | SILVERNAIL LAUREN P — Director | Grant/award (A): 7,339 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Opaleye Management Inc. — 10% owner | Sale (S): 15,204 @ $30.37 · Sale (S): 15,000 @ $30.80 | EDGAR |
| 2025-06-05 | 4 | Opaleye Management Inc. — 10% owner | Sale (S): 3,000 @ $30.04 · Sale (S): 1,796 @ $30.02 | EDGAR |
| 2025-05-14 | 4 | Opaleye Management Inc. — 10% owner | Sale (S): 10,000 @ $25.90 · Sale (S): 5,000 @ $26.59 | EDGAR |
| 2025-05-14 | 4/A | Opaleye Management Inc. — 10% owner | Sale (S): 5,000 @ $29.64 | EDGAR |
| 2025-05-14 | 4/A | Opaleye Management Inc. — 10% owner | Sale (S): 5,000 @ $30.01 | EDGAR |
| 2025-04-07 | 4 | BOLL ANDREW R. — Chief Financial Officer | Option exercise (M): 346,500 @ $0 · Tax withholding (F): 136,745 @ $23.09 · Option exercise (M): 346,500 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | SAHAREK JOHN P. — CEO & President, ImprimisRx | Option exercise (M): 277,200 @ $0 · Tax withholding (F): 109,475 @ $23.09 · Option exercise (M): 277,200 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | BAUM MARK L — Chief Executive Officer, Director, 10% owner | Option exercise (M): 762,300 @ $0 · Tax withholding (F): 300,363 @ $23.09 · Option exercise (M): 762,300 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | Opaleye Management Inc. — 10% owner | Sale (S): 5,000 @ $30.01 | EDGAR |
| 2025-03-20 | 4 | Opaleye Management Inc. — 10% owner | Sale (S): 5,000 @ $29.64 | EDGAR |
| 2025-03-04 | 4 | Opaleye Management Inc. — 10% owner | Sale (S): 5,000 @ $28.05 | EDGAR |
| 2025-01-24 | 4 | Opaleye Management Inc. — 10% owner | Sale (S): 20,000 @ $35.59 | EDGAR |
| 2025-01-08 | 4 | Shojaei Amir — CHIEF SCIENTIFIC OFFICER | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-09-13 | 4 | SAHAREK JOHN P. — CEO of ImprimisRx | Option exercise (M): 90,000 @ $7.37 · Tax withholding (F): 45,140 @ $41.37 · Option exercise (M): 90,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Sternberg Perry J. — Director | Grant/award (A): 8,347 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Makary Martin A. — Director | Grant/award (A): 8,347 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Graves Adrienne L — Director | Grant/award (A): 8,347 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | SILVERNAIL LAUREN P — Director | Grant/award (A): 8,347 (derivative) @ $0 | EDGAR |
| 2024-04-25 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 20,000 @ $9.97 | EDGAR |
| 2024-04-24 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 11,715 @ $10.29 · Purchase (P): 8,285 @ $10.15 | EDGAR |
| 2024-04-19 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 29,400 @ $10.56 | EDGAR |
| 2024-03-28 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 50,000 @ $12.82 | EDGAR |
| 2024-03-25 | 4 | BAUM MARK L — CHIEF EXECUTIVE OFFICER, Director | Purchase (P): 9,000 @ $11.59 | EDGAR |
| 2024-03-22 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 50,600 @ $9.65 | EDGAR |
| 2024-03-06 | 4 | SAHAREK JOHN P. — CEO of ImprimisRx | Option exercise (M): 5,000 @ $8.75 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | SAHAREK JOHN P. — CEO of ImprimisRx | Option exercise (M): 30,000 @ $10.67 · Option exercise (M): 12,616 @ $10.67 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | BOLL ANDREW R. — CHIEF FINANCIAL OFFICER | Option exercise (M): 45,000 @ $10.67 · Option exercise (M): 18,480 @ $10.67 · Option exercise (M): 45,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | BAUM MARK L — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 150,000 @ $10.67 · Option exercise (M): 59,836 @ $10.67 · Option exercise (M): 150,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — HARROW, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-03 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-24 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-24 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-10 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=HROW returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →